Organon & Co. (OGN): Price and Financial Metrics
GET POWR RATINGS... FREE!
OGN Stock Price Chart Interactive Chart >
OGN Price/Volume Stats
|Current price||$35.86||52-week high||$39.47|
|Prev. close||$34.92||52-week low||$28.42|
|Day high||$36.08||Avg. volume||1,956,777|
|50-day MA||$34.99||Dividend yield||3.12%|
|200-day MA||$33.87||Market Cap||9.10B|
Organon & Co. (OGN) Company Bio
Organon & Co. Organon & Co. is a science-based global pharmaceutical company. The Company is engaged in developing and delivering health solutions through a portfolio of prescription therapies within women's health, biosimilars and established brands. Its women's health portfolio includes Nexplanon or Implanon NXT, which is a patented long-acting reversible contraceptive. Its operating segments include the Organon Products segment. The Organon Products segment is engaged in developing and delivering health solutions through its portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's products segment portfolio includes: Women's Health, Biosimilars and Established Brands. Women's Health contains contraception and fertility brands, such as Nexplanon or Implanon NXT, NuvaRing and elonva. The Company's Biosimilars portfolio consists of three immunology products: Brenzys, Renflexis and Hadlima; and two oncology products: Ontruzant and Aybintio.
Most Popular Stories View All
OGN Latest News Stream
|Loading, please wait...|
OGN Latest Social Stream
View Full OGN Social Stream
Latest OGN News From Around the Web
Below are the latest news stories about Organon & Co that investors may wish to consider to help them evaluate OGN as an investment opportunity.
Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Organon & Co...
Organon (NYSE:OGN) declares $0.28/share quarterly dividend, in line with previous. Forward yield 3.08% Payable March 17; for shareholders of record Feb. 28; ex-div Feb. 25. See OGN Dividend Scorecard, Yield Chart, & Dividend Growth....
JERSEY CITY, N.J., February 17, 2022--Organon reports results for the fourth quarter and full year ended December 31, 2021
Organon Acquires Contraceptive Products, Marvelon® and Mercilon®, in the People’s Republic of China, including Hong Kong and Macau, and Agrees to Acquire these Products in Vietnam
JERSEY CITY, N.J., February 16, 2022--Organon Acquires Marvelon® and Mercilon®, in the People’s Republic of China, including Hong Kong, Macau, Agrees to Acquire these Products in Vietnam
A look at the shareholders of Organon & Co. ( NYSE:OGN ) can tell us which group is most powerful. Large companies...
OGN Price Returns
|Ex-Dividend Date||Type||Payout Amount||Change|
|Loading, please wait...|